Key result
Undiagnosed hypertension affects ~27% of hypertensive middle-aged men and is linked to higher cardiometabolic risk.
Why the study?
The current prevalence and associated cardiometabolic risk profiles of suspected and diagnosed untreated hypertension in middle-aged Lithuanian men needed to be estimated.
What is the prevalence and cardiometabolic risk profile of suspected and untreated hypertension in middle-aged Lithuanian men?
Population
52 012 male participants aged 40–54 years in the LitHiR Primary Prevention Programme
Comparison
Normotensive vs suspected hypertensive vs diagnosed untreated hypertensive groups
Design
Cross-sectional study
Authors
Loading...
Undiagnosed/untreated hypertension clusters with high cardiometabolic risk in middle-aged Lithuanian men; leaves open whether targeted screening improves outcomes.
What is the prevalence and cardiometabolic risk profile of suspected and untreated hypertension in middle-aged Lithuanian men?
A significant proportion of middle-aged men in Lithuania have undiagnosed or untreated hypertension, which is strongly associated with other cardiometabolic risk factors like dyslipidemia.
Šileikienė et al. (2026) studied this question. 26.84% of middle-aged Lithuanian men with hypertensive BP are undiagnosed and 18.57% of diagnosed men remain untreated, with higher cardiometabolic risk in these groups.